Skip to main content

Advertisement

SpringerLink
Log in

The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells

  • Original Paper
  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Pdcd4 (programmed cell death protein 4) was identified as a gene up-regulated during apoptosis and, additionally, seems to have a function as a tumor suppressor. However, there are conflicting data concerning its role in programmed cell death and most results for its action as an inhibitor for neoplastic transformation are derived from experiments with epidermal cells. Therefore, we were interested to investigate if the action of Pdcd4 might be cell type specific. For that purpose we examined the expression of Pdcd4 and several other proteins in various tumor cell lines. We could not find any correlation of Pdcd4 levels and expression of proteins associated with cell cycle and/or apoptosis in different cell lines. Furthermore, we stably transfected two cell lines (Bon-1 and HCT116) to over-express Pdcd4 and analyzed protein expression. Although we found several regulated proteins none of these proteins were affected in both cell lines in the same manner. For instance, dUTPase expression was reduced in Bon-1 cells but not changed in HCT116 cells. This regulation might be important for the sensitivity of cells to anti-cancer drugs like inhibitors of thymidilate synthase. Therefore, we conclude that the function of Pdcd4 might be cell type specific. A role for Pdcd4 in apoptosis or as a tumor suppressor might be limited to certain cell types.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Göke A, Göke R, Knolle A et al (2002) DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem Biophys Res Commun 297(1):78–82

    Article  PubMed  Google Scholar 

  2. Shibahara K, Asano M, Ishida Y et al (1995) Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166(2):297–301

    Article  PubMed  CAS  Google Scholar 

  3. Onishi Y, Kizaki H (1996) Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem Biophys Res Commun 228(1):7–13

    Article  PubMed  CAS  Google Scholar 

  4. Matsuhashi S, Yoshinaga H, Yatsuki H, Tsugita A, Hori K (1997) Isolation of a novel gene from a human cell line with Pr-28 MAb which recognizes a nuclear antigen involved in the cell cycle. Res Comm Biochem Cell Mol Biol 1(1):109–120

    CAS  Google Scholar 

  5. Azzoni L, Zatsepina O, Abebe B et al (1998) Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol 161(7):3493–3500

    PubMed  CAS  Google Scholar 

  6. Schlichter U, Burk O, Worpenberg S, Klempnauer KH (2001) The chicken Pdcd4 gene is regulated by v-Myb. Oncogene 20(2):231–239

    Article  PubMed  CAS  Google Scholar 

  7. Appl H, Klempnauer KH (2002) Targeted disruption of c-myb in the chicken pre B-cell line DT40. Oncogene 21(19):3076–3081

    Article  PubMed  CAS  Google Scholar 

  8. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH (2004) Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23(49):8135–8145

    Article  PubMed  CAS  Google Scholar 

  9. Jansen AP, Camalier CE, Stark C, Colburn NH (2004) Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3(2):103–110

    PubMed  CAS  Google Scholar 

  10. Zhang H, Ozaki I, Mizuta T et al (2006) Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 8:8

    CAS  Google Scholar 

  11. Cmarik JL, Min H, Hegamyer G et al (1999) Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96(24):14037–14042

    Article  PubMed  CAS  Google Scholar 

  12. Yang HS, Jansen AP, Nair R et al (2001) A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20(6):669–676

    Article  PubMed  CAS  Google Scholar 

  13. Jansen AP, Camalier CE, Colburn NH (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65(14):6034–6041

    Article  PubMed  CAS  Google Scholar 

  14. Yang HS, Jansen AP, Komar AA et al (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23(1):26–37

    Article  PubMed  Google Scholar 

  15. Lankat-Buttgereit B, Gregel C, Knolle A et al (2004) Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol Cell Endocrinol 214(1–2):149–153

    Article  PubMed  CAS  Google Scholar 

  16. Onishi Y, Hashimoto S, Kizaki H (1998) Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 215(2):453–459

    Article  PubMed  CAS  Google Scholar 

  17. Chen Y, Knosel T, Kristiansen G et al (2003) Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200(5):640–646

    Article  PubMed  CAS  Google Scholar 

  18. Carinci F, Lo Muzio L, Piattelli A et al (2005) Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunopathol Pharmacol 18(3):513–524

    PubMed  CAS  Google Scholar 

  19. Yang HS, Knies JL, Stark C, Colburn NH (2003) Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22(24):3712–3720

    Article  PubMed  CAS  Google Scholar 

  20. Zhang Y, Ohyashiki JH, Takaku T, Shimizu N, Ohyashiki K (2006) Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br J Cancer 94(4):599–608

    Article  PubMed  CAS  Google Scholar 

  21. Hammerl P, Hartl A, Thalhamer J (1993) Particulate nitrocellulose as a solid phase for protein immobilization in immuno-affinity chromatography. J Immunol Methods 165(1):59–66

    Article  PubMed  CAS  Google Scholar 

  22. Diettrich O, Gallert F, Hasilik A (1996) Purification of lysosomal membrane proteins from human placenta. Eur J Cell Biol 69(2):99–106

    PubMed  CAS  Google Scholar 

  23. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20(18):3551–3567

    Article  PubMed  CAS  Google Scholar 

  24. Göke R, Barth P, Schmidt A, Samans B, Lankat-Buttgereit B (2004) Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 287(6):C1541–C1546. Epub 2004 Aug 18

    Google Scholar 

  25. Yang HS, Matthews CP, Clair T et al (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26(4):1297–1306

    Article  PubMed  Google Scholar 

  26. Yoshinaga H, Matsuhashi S, Fujiyama C, Masaki Z (1999) Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 49(12):1067–1077

    Article  PubMed  CAS  Google Scholar 

  27. Matsuhashi S, Watanabe T, Hori K (1987) An antigen expressed in proliferating cells at late G1-S phase. Exp Cell Res 170(2):351–362

    Article  PubMed  CAS  Google Scholar 

  28. Kang MJ, Ahn HS, Lee JY, Matsuhashi S, Park WY (2002) Up-regulation of PDCD4 in senescent human diploid fibroblasts. Biochem Biophys Res Commun 293(1):617–621

    Article  PubMed  CAS  Google Scholar 

  29. Böhm M, Sawicka K, Siebrasse JP et al (2003) The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22(31):4905–4910

    Article  PubMed  Google Scholar 

  30. Yoshinaga H, Matsuhashi S, Ahanek J, Masaki Z, Hori K (1997) Expression and identification of H731 gene product in HeLa cells. Res Commun Biochem Cell Mol Biol 1:121–131

    CAS  Google Scholar 

  31. Göke R, Gregel C, Göke A et al (2004) Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann N Y Acad Sci 1014:220–221

    Article  PubMed  Google Scholar 

  32. Ladner RD, Carr SA, Huddleston MJ, McNulty DE, Caradonna SJ (1996) Identification of a consensus cyclin-dependent kinase phosphorylation site unique to the nuclear form of human deoxyuridine triphosphate nucleotidohydrolase. J Biol Chem 271(13):7752–7757

    Article  PubMed  CAS  Google Scholar 

  33. Grasser FA, Romeike BF, Niedobitek G, Nicholls J, Kremmer E (2001) dUTPase in human neoplastic cells as a potential target for therapeutic intervention. Curr Protein Pept Sci 2(4):349–360

    Article  PubMed  CAS  Google Scholar 

  34. Canman CE, Lawrence TS, Shewach DS, Tang HY, Maybaum J (1993) Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate. Cancer Res 53(21):5219–5224

    PubMed  CAS  Google Scholar 

  35. Fleischmann J, Kremmer E, Muller S et al (1999) Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours. Int J Cancer 84(6):614–617

    Article  PubMed  CAS  Google Scholar 

  36. Ladner RD, Lynch FJ, Groshen S et al (2000) dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer. Cancer Res 60(13):3493–3503

    PubMed  CAS  Google Scholar 

  37. Koehler SE, Ladner RD (2004) Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition. Mol Pharmacol 66(3):620–626

    PubMed  CAS  Google Scholar 

  38. Mo H, Elson CE (2004) Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 229(7):567–585

    CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by the Wilhelm Sander Stiftung Grant 2005.090.1 (to R. Göke).

Author information

Authors and Affiliations

  1. Clinical Research Unit for Gastrointestinal Endocrinology, University Hospital of Giessen and Marburg, Baldingerstrasse, 35033, Marburg, Germany

    Brigitte Lankat-Buttgereit, Barbara Lenschen, Harald Schmidt & Rüdiger Göke

Authors
  1. Brigitte Lankat-Buttgereit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Lenschen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harald Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rüdiger Göke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brigitte Lankat-Buttgereit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lankat-Buttgereit, B., Lenschen, B., Schmidt, H. et al. The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 13, 157–164 (2008). https://doi.org/10.1007/s10495-007-0153-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-007-0153-x

Keywords

Search

Navigation